Near-Perfect Cure Rate for New HCV Medication in People with Genotype 2
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The HepatitisC.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- AbbVie Applies for FDA OK of Hep C Treatment Glecaprevir/Pibrentasvir. (2016). Hep. Retrieved 26 February 2017, from https://www.hepmag.com/article/abbvie-applies-fda-ok-hep-c-treatment-glecaprevirpibrentasvir
- Le, T. & Wogen, J. (2003). Evaluation of hepatitis C genotype testing in newly diagnosed hepatitis C managed care patients. Hepatology, 38, 749-749. http://dx.doi.org/10.1016/s0270-9139(03)81262-4
- Near-Perfect Hep C Cure Rate for Glecaprevir/Pibrentasvir in Genotype 2s. (2016). Hep. Retrieved 26 February 2017, from https://www.hepmag.com/article/nearperfect-hep-c-cure-rate-glecaprevirpibrentasvir-genotype-2s